Top Markets
#1 Derive Derive +33.59%
#2 Cross Cross +17.56%
#3 The Bitcoin Bull The Bitcoin Bull +14.37%
#4 Audiera Audiera +9.42%
#5 Gama Token Gama Token +9.19%
#6 Geodnet Geodnet +9.10%
#7 Velvet Velvet +8.40%
#8 Biconomy Biconomy +7.55%
#9 Starpower Starpower +7.38%
#10 Based Based +7.36%
Coin of the day
Derive Derive
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Gujarat Terce Laboratories Limited Gujarat Terce Laboratories Limited

Gujarat Terce Laboratories Limited

GUJTERC
Clasificación en acciones #35875
Gujarat Terce Laboratories Ltd. operates as a pharmaceutical enterprise,... Gujarat Terce Laboratories Ltd. operates as a pharmaceutical enterprise, focusing on the production and distribution of various medicinal items. Its comprehensive product range addresses diverse therapeutic areas such as anti-fungal, anti-malarial, and antibiotic treatments, in addition to ayurvedic, cardiovascular, gastrointestinal, gynecological, and respiratory care. The company also offers nutraceuticals, pain relief solutions, and other specialized pharmaceutical products. Mr. N.P. Prajapati founded the company on March 28, 1985, and it is presently based in Ahmedabad, India.
Precio por acción
$0.42708845
Última sincronización: 2026-08-14
Capitalización bursátil
$3.33M
Cambio (1 día)
4.48%
Cambio (1 año)
-9.84%
País
IN
Comercio Gujarat Terce Laboratories Limited (GUJTERC)

Categoría

Healthcare
Ganancias de Gujarat Terce Laboratories Limited (GUJTERC)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Gujarat Terce Laboratories Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Gujarat Terce Laboratories Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US